Black children, as well as Hispanic kids and other ethnic minorities, are less likely to receive bystander CPR during an out-of-hospital cardiac arrest (OHCA) than their white counterparts, according to a Journal of the American Heart Association study published July 10.

Boston Scientific’s Watchman device, an alternative to blood thinners in atrial fibrillation patients unable to take medications like warfarin, has for years been touted as a safe, effective therapy to reduce patients’ stroke risk.

Research published in Circulation: Cardiovascular Quality and Outcomes July 9 suggests the public health burden of pulseless in-hospital cardiac arrests is around 38% higher in adults and 18% higher in children than was previously believed.

Biotronik on July 8 announced its BIOMONITOR III injectable cardiac monitor, a diagnostic tool designed to document suspected arrhythmias, has been cleared by the FDA.

Four universities were awarded research grants by the American Heart Association on June 24, each set to receive more than $3.7 million for a range of studies focused on arrhythmias and sudden cardiac arrest.

Researchers at the University of Washington are hoping to catch out-of-hospital cardiac arrests early with an algorithm that, when integrated with smart speakers like the Google Home or Amazon Alexa, can monitor people for audible cardiac arrest symptoms while they sleep.

More than 14 million European adults aged 65 and up will have developed atrial fibrillation by 2060, according to a paper published June 6 in EP Europace.

Biotronik is targeting a minimum of 40% female enrollment for its newest project, a large-scale prospective study of sex differences in patients with non-ischemic cardiomyopathy (NICM) and an implanted cardiovascular device.